Diseases of the Liver and Gallbladder
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
siRNA - Small Interfering RNAs
piRNA - Piwi-interacting RNAs
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 30, 2026

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR
Published on: March 1, 2019
Hai-Di Li1,2,3,4, Xiao-Sa Du1,2,3,4, Hui-Min Huang1,2,3,4
1The Key Laboratory of Major Autoimmune Diseases, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, Anhui, China.
Noncoding RNAs (ncRNAs) are key players in alcoholic liver disease (ALD) progression, impacting liver damage, inflammation, and fibrosis. These molecules show promise as diagnostic markers and therapeutic targets for ALD.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: